CCRM Revenue and Competitors

Commercialization, Cell Reprogramming, Cell Manufacturing, Biomaterials + Tissue Mimetics, Integration of Science + Business, Industry Consortium, Contract Services Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM's promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and bioengineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM is a Canadian, not-for-profit organization dedicated to supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. CCRM receives funding from the Government of Canada and the Province of Ontario.